Abstract:
BACKGROUND:It has been recommended that onset of antidepressant action be assessed using survival analyses with assessments taken at least twice per week. However, such an assessment schedule is problematic to implement. The present study assessed the feasibility of comparing onset of action between treatments using a categorical repeated measures approach with a traditional assessment schedule. METHOD:Four scenarios representative of antidepressant clinical trials were created by varying mean improvements over time. Two assessment schedules were compared within the simulated 8-week studies: (i) 'frequent' assessment--16 postbaseline visits (twice-weekly for 8 weeks); (ii) 'traditional' assessment--5 postbaseline visits (Weeks 1, 2, 4, 6, and 8). Onset was defined as a 20 per cent improvement from baseline, and had to be sustained at all subsequent assessments. Differences between treatments were analysed with a survival analysis (KM = Kaplan-Meier product limit method) and a categorical mixed-effects model repeated measures analysis (MMRM-CAT). RESULTS:More frequent assessments resulted in small reductions in empirical standard errors compared with traditional assessments for both analytic methods. More frequent assessments altered estimates of treatment group differences in KM such that power was increased when the difference between treatments was increasing over time, but power decreased when the treatment difference decreased over time. More frequent assessments had a minimal effect on estimates of treatment group differences in MMRM-CAT. The MMRM-CAT analysis of data from a traditional assessment schedule provided adequate control of type I error, and had power comparable to or greater than that with KM analyses of data from either a frequent or a traditional assessment schedule. CONCLUSION:In the scenarios tested in this study it was reasonable to assess treatment group differences in onset of action with MMRM-CAT and a traditional assessment schedule. Additional research is needed to assess whether these findings hold in data with drop-out and across definitions of onset.
journal_name
Stat Medjournal_title
Statistics in medicineauthors
Mallinckrodt CH,Detke MJ,Kaiser CJ,Watkin JG,Molenberghs G,Carroll RJdoi
10.1002/sim.2309subject
Has Abstractpub_date
2006-07-30 00:00:00pages
2384-97issue
14eissn
0277-6715issn
1097-0258journal_volume
25pub_type
杂志文章abstract::This paper presents a mixture model which combines features of the usual Cox proportional hazards model with those of a class of models, known as mixtures-of-experts. The resulting model is more flexible than the usual Cox model in the sense that the log hazard ratio is allowed to vary non-linearly as a function of th...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19990515)18:9<1119::aid-si
更新日期:1999-05-15 00:00:00
abstract::We obtained maximum likelihood estimates (MLEs) of the proportion cured pi c and mean log survival time mu t for a sample of 4355 patients with intraocular melanoma whose survival times subsequent to treatment were assumed to follow a log-normal distribution. Following stratification by tumour size, MLEs of pi c and m...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780090814
更新日期:1990-08-01 00:00:00
abstract::I derive the locally most powerful rank tests for acceleration against semi-parametric alternatives when some patients are cured of the disease. I consider some particular classes of alternatives and present simulation results to verify the validity of the proposed tests. Real data from clinical trials for childhood l...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780141905
更新日期:1995-10-15 00:00:00
abstract::The development of drugs and biologicals whose mechanisms of action may extend beyond their target indications has led to a need to identify unexpected potential toxicities promptly even while blinded clinical trials are under way. One component of recently issued FDA rules regarding safety reporting requirements rais...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7129
更新日期:2017-01-15 00:00:00
abstract::Meta-analyses of data from epidemiological studies are often based on odds ratios (ORs) or relative risks (RRs) and their 95 per cent confidence intervals (CIs) as reported by the authors. Where possible ORs, RRs and CIs should be checked against the source data. Some simple methods are presented for checking the vali...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19990815)18:15<1973::aid-s
更新日期:1999-08-15 00:00:00
abstract::Biostatistical concepts and methods apply to various problems arising in actual U.S. legal cases. These involve: measures of association, assessing the potential effect of omitted variables and the Peters-Belson approach to regression. In particular, we present the inapplicability of Fisher's exact test in the case wh...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780141505
更新日期:1995-08-15 00:00:00
abstract::An observed confidence distribution is proposed as a measure of strength of evidence for practically equivalent efficacies of two treatments. The concept is independent of prior opinions about relevant sizes of a difference in efficacy. It also avoids retrospective power calculations for trials with missed recruitment...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780071207
更新日期:1988-12-01 00:00:00
abstract::The correct identification of change-points during ongoing outbreak investigations of infectious diseases is a matter of paramount importance in epidemiology, with major implications for the management of health care resources, public health and, as the COVID-19 pandemic has shown, social live. Onsets, peaks, and infl...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8807
更新日期:2021-02-20 00:00:00
abstract::Competing compartment models of different complexities have been used for the quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging data. We present a spatial elastic net approach that allows to estimate the number of compartments for each voxel such that the model complexity is not fixed a pri...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.5997
更新日期:2014-03-15 00:00:00
abstract::The effective dose (ED) is the pharmaceutical dosage required to produce a therapeutic response in a fixed proportion of the patients. When only one drug is considered, the problem is a univariate one and has been well-studied. However, in the multidimensional setting, that is, in the presence of combinations of agent...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6226
更新日期:2014-10-30 00:00:00
abstract::Logistic regression analysis may well be used to develop a prognostic model for a dichotomous outcome. Especially when limited data are available, it is difficult to determine an appropriate selection of covariables for inclusion in such models. Also, predictions may be improved by applying some sort of shrinkage in t...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(20000430)19:8<1059::aid-si
更新日期:2000-04-30 00:00:00
abstract::When interpreting screening mammograms radiologists decide whether suspicious abnormalities exist that warrant the recall of the patient for further testing. Previous work has found significant differences in interpretation among radiologists; their false-positive and false-negative rates have been shown to vary widel...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2633
更新日期:2007-03-30 00:00:00
abstract::Comparative Poisson trials of prophylactic interventions, such as vaccines, can be lengthy and costly. We evaluate two easily implemented approaches to reduce numbers of disease cases and person years of follow up (N(u+t)) for comparative Poisson trials with fixed numbers of cases (T); (i) altering k the portion of N(...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.1724
更新日期:2004-04-30 00:00:00
abstract::Orthogonal polynomial scores (OPS) is a simple, biologically meaningful approach to characterize longitudinal data in phase I and II clinical pharmacology trials. It describes average, linear, quadratic and higher order polynomial characteristics of each subject's response over time with use of composite scores comput...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780120703
更新日期:1993-04-15 00:00:00
abstract::Vaccination in populations can have several kinds of effects. Establishing that vaccination produces population-level effects beyond the direct effects in the vaccinated individuals can have important consequences for public health policy. Formal methods have been developed for study designs and analysis that can esti...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.7392
更新日期:2018-01-30 00:00:00
abstract::In many medical applications, combining information from multiple biomarkers could yield a better diagnosis than any single one on its own. When there is a lack of a gold standard, an algorithm of classifying subjects into the case and non-case status is necessary for combining multiple markers. The aim of this paper ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.6780
更新日期:2016-04-15 00:00:00
abstract::We have developed a method to longitudinally classify subjects into two or more prognostic groups using longitudinally observed values of markers related to the prognosis. We assume the availability of a training data set where the subjects' allocation into the prognostic group is known. The proposed method proceeds i...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.3849
更新日期:2010-12-30 00:00:00
abstract::There is growing interest in how best to adapt and readapt treatments to individuals to maximize clinical benefit. In response, adaptive treatment strategies (ATS), which operationalize adaptive, sequential clinical decision making, have been developed. From a patient's perspective an ATS is a sequence of treatments, ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4512
更新日期:2012-07-30 00:00:00
abstract::In this paper the following problem of clinical research is explored. Several potential new treatments are available for use against a certain disease. These are evaluated in a series of pilot studies which will constitute phase II clinical trials. The most promising will then be compared with a standard treatment in ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780050510
更新日期:1986-09-01 00:00:00
abstract::Patients who switch treatment groups in randomized clinical trials can cause problems in the interpretation of the results. Although the intention-to-treat method is recognized as being the most reliable analysis, it may result in an underestimate of the treatment effect if there have been patients who switch treatmen...
journal_title:Statistics in medicine
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1002/(SICI)1097-0258(19961015)15:19<2069::AID-S
更新日期:1996-10-15 00:00:00
abstract::Paired count data usually arise in medicine when before and after treatment measurements are considered. In the present paper we assume that the correlated paired count data follow a bivariate Poisson distribution in order to derive the distribution of their difference. The derived distribution is shown to be the same...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2382
更新日期:2006-06-15 00:00:00
abstract::To update the British growth reference, anthropometric data for weight, height, body mass index (weight/height2) and head circumference from 17 distinct surveys representative of England, Scotland and Wales (37,700 children, age range 23 weeks gestation to 23 years) were analysed by maximum penalized likelihood using ...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:
更新日期:1998-02-28 00:00:00
abstract::Tree-based methods have become popular for analyzing complex data structures where the primary goal is risk stratification of patients. Ensemble techniques improve the accuracy in prediction and address the instability in a single tree by growing an ensemble of trees and aggregating. However, in the process, individua...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4492
更新日期:2012-07-10 00:00:00
abstract::Mediation analyses can help us to understand the biological mechanism in which an exposure or treatment affects an outcome. Single mediator analyses have been used in various applications, but may not be appropriate for analyzing intricate mechanisms involving multiple mediators that affect each other. Thus, in this a...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8485
更新日期:2020-05-15 00:00:00
abstract::The lifetime risk of a clinical condition is the probability of onset of the condition during one's lifespan. Recent advances in Alzheimer's disease (AD) research have identified screening tests for biomarkers that can identify persons who are in the earliest stages of the AD process but who do not yet have any clinic...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.8056
更新日期:2019-04-30 00:00:00
abstract::I reflect on the statistical methods of the Christakis-Fowler studies on network-based contagion of traits by checking the sensitivity of these kinds of results to various alternate specifications and generative mechanisms. Despite the honest efforts of all involved, I remain pessimistic about establishing whether bin...
journal_title:Statistics in medicine
pub_type: 评论,杂志文章
doi:10.1002/sim.5551
更新日期:2013-02-20 00:00:00
abstract::Assessment of quality of life is becoming standard in clinical trials. A popular method for measuring quality of life is with instruments which utilize multiple-item subscales, in which each item is scored on a Likert scale. Most statistical methods for the analysis of quality of life data in clinical trials do not ex...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19991115)18:21<2917::aid-s
更新日期:1999-11-15 00:00:00
abstract::Several relative risk models for survival time data in drug combination therapy are derived and their properties are discussed. The main intention of this paper is to clarify the differences among the models in order to help to choose the appropriate one in a given situation. The models are motivated by discussing the...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.4780091216
更新日期:1990-12-01 00:00:00
abstract::R2 has been criticized as a measure of model performance when predicting a dichotomous outcome, both because its value is often low and because it is sensitive to the prevalence of the event of interest. The C statistic is more widely used to measure model performance in a 0/1 setting. We use a simple parametric famil...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/(sici)1097-0258(19990228)18:4<375::aid-sim
更新日期:1999-02-28 00:00:00
abstract::Inference for randomized clinical trials is generally based on the assumption that outcomes are independently and identically distributed under the null hypothesis. In some trials, particularly in infectious disease, outcomes may be correlated. This may be known in advance (e.g. allowing randomization of family member...
journal_title:Statistics in medicine
pub_type: 杂志文章
doi:10.1002/sim.2977
更新日期:2008-03-15 00:00:00